Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Phase 3 Interventional

Study of Quemliclustat and Chemotherapy Versus Placebo and Chemotherapy in Patients With Metastatic Pancreatic Ductal Adenocarcinoma

ClinicalTrials.gov ID: NCT06608927

Public ClinicalTrials.gov record NCT06608927. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 19, 2026, 10:12 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 3 Trial of Quemliclustat and Chemotherapy Versus Placebo and Chemotherapy in Patients With Treatment-Naive Metastatic Pancreatic Ductal Adenocarcinoma

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to compare overall survival of quemliclustat, nab-paclitaxel and gemcitabine versus placebo, nab-paclitaxel and gemcitabine in all randomized patients.

Study identification

NCT ID
NCT06608927
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Arcus Biosciences, Inc.
Industry
Enrollment
610 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 13, 2024 (Actual)
Primary completion
Nov 30, 2030 (Estimated)
Completion
Nov 30, 2030 (Estimated)
Last update posted
Sep 29, 2026

2024 – 2030

United States locations

U.S. sites
49
U.S. states
25
U.S. cities
44
Facility City State ZIP Site status
Research Site Phoenix Arizona 85054 —
Research Site Tucson Arizona 85724 —
Research Site La Jolla California 92093 —
Research Site Los Alamitos California 90720 —
Research Site Los Angeles California 90033-5315 —
Research Site Roseville California 95661 —
Research Site San Francisco California 94158 —
Research Site Santa Monica California 90404 —
Research Site Denver Colorado 80218 —
Research Site New Haven Connecticut 06520 —
Research Site Jacksonville Florida 32224-1865 —
Research Site Miami Florida 33176 —
Research Site Atlanta Georgia 30318 —
Research Site Atlanta Georgia 30322 —
Research Site Arlington Heights Illinois 60005 —
Research Site Chicago Illinois 60611 —
Research Site Indianapolis Indiana 46202 —
Research Site Wichita Kansas 67208 —
Research Site Baton Rouge Louisiana 70809 —
Research Site Ann Arbor Michigan 48109 —
Research Site Grand Rapids Michigan 49503 —
Research Site Minneapolis Minnesota 55404 —
Research Site Rochester Minnesota 55905 —
Research Site Hattiesburg Mississippi 39401 —
Research Site Kansas City Missouri 64111 —
Research Site Omaha Nebraska 68105 —
Research Site New Brunswick New Jersey 08903-2681 —
Research Site Buffalo New York 14263 —
Research Site New York New York 10016 —
Research Site New York New York 10032 —
Research Site New York New York 10065 —
Research Site New York New York 10128 —
Research Site Rochester New York 14642 —
Research Site Cleveland Ohio 44106 —
Research Site Oklahoma City Oklahoma 73104 —
Research Site Philadelphia Pennsylvania 19111-2497 —
Research Site Pittsburgh Pennsylvania 15232 —
Research Site Nashville Tennessee 37232 —
Research Site Austin Texas 78705 —
Research Site Dallas Texas 75246 —
Research Site Dallas Texas 75390 —
Research Site Houston Texas 77030 —
Research Site San Antonio Texas 78240 —
Research Site Webster Texas 77598 —
Research Site Fairfax Virginia 22031 —
Research Site Seattle Washington 98101 —
Research Site Spokane Washington 99208 —
Research Site Vancouver Washington 98684 —
Research Site Madison Wisconsin 53792 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 62 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06608927, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 29, 2026 · Synced Oct 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT06608927 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →